China Shineway Pharmaceutical Group Limited China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

2877

Classifica tra le azioni #10981
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Prezzo delle azioni
$0.95560894
Capitalizzazione di mercato
$721.87M
Variazione (1 giorno)
0.40%
Variazione (1 anno)
-95.04%
Paese
CN
Scambia China Shineway Pharmaceutical Group Limited (2877)

Categoria

Healthcare
Utile per China Shineway Pharmaceutical Group Limited (2877)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di China Shineway Pharmaceutical Group Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di China Shineway Pharmaceutical Group Limited dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti